Showing results (711-720 of 1,107) with videos related to
Sort By:
Pageof 111
Radiographics : a Review Publication of the Radiological Society of North America, Inc|January 5, 2023
Imaging Care for Transgender and Gender Diverse Patients: Best Practices and RecommendationsCrysta B Iv Kyrazis, Erica B Stein, Evelyn F Carroll, et al.Investigative Ophthalmology & Visual Science|July 12, 2011
Frizzled 4 is required for retinal angiogenesis and maintenance of the blood-retina barrierKim T Paes, Ernest Wang, Kathy Henze, et al.Journal of the American Society for Mass Spectrometry|July 13, 2018
Correction to: Fungal Secretome Analysis Via PepSAVI-MS: Identification of the Bioactive Peptide KP4 from Ustilago maydisChristine L Kirkpatrick, Nicole C Parsley, Tessa E Bartges, et al.Journal of the American Society for Mass Spectrometry|February 7, 2018
Fungal Secretome Analysis via PepSAVI-MS: Identification of the Bioactive Peptide KP4 from Ustilago maydisChristine L Kirkpatrick, Nicole C Parsley, Tessa E Bartges, et al.The FEBS Journal|June 23, 2026
Circadian rhythms of metabolite abundance in Drosophila are largely driven by time of feedingSumit Saurabh, Charlene Y P Guerrero, Madelyn R Cusick, et al.American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 5, 2010
Exercise training reverses impaired skeletal muscle metabolism induced by artificial selection for low aerobic capacitySarah J Lessard, Donato A Rivas, Erin J Stephenson, et al.Chemical Science|August 25, 2020
Quinone methide dimers lacking labile hydrogen atoms are surprisingly excellent radical-trapping antioxidantsMark A R Raycroft, Jean-Philippe R Chauvin, Matthew S Galliher, et al.Circulation. Cardiovascular Quality and Outcomes|July 11, 2025
Quantifying Patient Preferences About Features of Nonstatin Lipid-Lowering Therapies: A Discrete Choice Experiment in the United StatesShelby D Reed, Jessie Sutphin, Juan Marcos Gonzalez, et al.Chemical Science|July 15, 2017
Ligand functionalization as a deactivation pathway in a fac-Ir(ppy)3-mediated radical additionJames J Devery Iii, James J Douglas, John D Nguyen, et al.Investigational New Drugs|June 25, 2019
Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancerHaris Zahoor, Maria C Mir, Pedro C Barata, et al.Pageof 111